SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-138829
Filing Date
2018-04-27
Accepted
2018-04-27 16:05:57
Documents
4
Period of Report
2018-06-08
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d543458ddef14a.htm DEF 14A 548948
2 GRAPHIC g543458g0421095402441.jpg GRAPHIC 1580
3 GRAPHIC g543458g0421095402566.jpg GRAPHIC 1445
4 GRAPHIC g543458g80d30.jpg GRAPHIC 68956
  Complete submission text file 0001193125-18-138829.txt   649790
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 18783847
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10